Helio Genomics is built on nearly a decade of research in DNA methylation and AI-driven early cancer detection. This is where we share what we are learning — educational deep-dives, research updates, and candid conversations with the experts advancing the field.
Stories from the lab
Educational articles on early cancer detection, genomics, and the science behind HelioLiver.
Early cancer diagnosis and artificial intelligence are both rapidly evolving fields — and where they converge, they are changing how we identify the DNA signatures that predict cancer as early as stage 1.
A HelioLiver patient story: living with Stage IV cirrhosis, John shares why he advocates for routine liver cancer surveillance.
Read moreWorld Liver Day tips for protecting your liver — from knowing your risk to talking with your doctor about surveillance options.
Read moreListen to our leadership share their latest insights on the oncology and diagnostic landscape.
Justin Chen Li, CEO of Helio Genomics, sits down with Nasdaq’s Kristina Ayanian to discuss how the AI-driven healthcare company is on a mission to save lives by detecting cancer early from a simple blood draw.
Watch InterviewFeatured in Precision Medicine Online. Catherine Shaffer interviews Helio Genomics CEO Justin Chen Li about applying deep learning and generative AI to new cancer diagnostics.
Read InterviewHelio Genomics CEO Justin Chen Li is interviewed by the Orange County Business Journal about recent research on multimodal epigenetic sequencing analysis (MESA).
Read InterviewDr. Richard A. Van Etten of UC Irvine’s Chao Family Comprehensive Cancer Center on the late-breaking ENCORE performance data for HelioLiver in early liver cancer detection.
Watch InterviewDr. Robert Gish joins Blue Faery, the Adrienne Wilson Liver Cancer Association, to discuss liver cancer awareness and early detection.
Watch InterviewAuthority Magazine’s Yitzi Weiner interviews Helio founder and chairman Dr. Shu Li on technology, resilience, and the mission to detect cancer early.
Read InterviewStanford hepatologist Dr. Mindie Nguyen on the ENCORE data published in Hepatology Communications, demonstrating HelioLiver’s performance for early liver cancer detection.
Watch InterviewA highly sensitive, multi-analyte blood test from Helio points to earlier detection of hepatocellular carcinoma and a future of widely accessible cancer detection.
Read ArticleDr. Robert Gish of Loma Linda University on the clinical landscape of HCC, the importance of early detection, and how the HelioLiver test works.
Watch WebinarSubscribe for new articles, interviews, and research milestones — or reach our team to learn more about HelioLiver and the science behind earlier detection.